KLK3 and Familial prostate cancer: Furthermore, our demonstration of reduced incidence of low–moderate grade but not high-grade prostate cancer among men with diabetes supports the possibility that low PSA levels, rather than lower tumour risk, may explain the observed reduced incidence of prostate cancer.